Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-IFNAR2 Antibody-PE (6Q627)
🥰Excellent
Catalog No. TMAY-00685P
Anti-IFNAR2 Antibody-PE (6Q627) is a PE-conjugated Mouse antibody targeting IFNAR2. Anti-IFNAR2 Antibody-PE (6Q627) can be used in FCM.
Anti-IFNAR2 Antibody-PE (6Q627)
Anti-IFNAR2 Antibody-PE (6Q627)
🥰Excellent
Catalog No. TMAY-00685P
Anti-IFNAR2 Antibody-PE (6Q627) is a PE-conjugated Mouse antibody targeting IFNAR2. Anti-IFNAR2 Antibody-PE (6Q627) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-IFNAR2 Antibody-PE (6Q627) is a PE-conjugated Mouse antibody targeting IFNAR2. Anti-IFNAR2 Antibody-PE (6Q627) can be used in FCM. |
| Ig Type | Monoclonal Mouse IgG1 |
| Clone | 6Q627 |
| Reactivity | Human |
| Verified Activity | Profile of anti-IFNAR2 reactivity on Jurkat cells analyzed by flow cytometry. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IFNAR2 (rh IFNAR2; TMPY-01642; NP_997468.1; Met 1-Lys 243) and conjugated with PE under optimum conditions, the unreacted PE was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Interferon-alpha/beta receptor beta chain (IFNAR2) is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulate Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. Initial cell-surface IFNAR2 expression at diagnosis assessed by flow cytometry was widely distributed but showed overall significantly higher expression in CML patients when compared with normal controls. In 15 fresh patients who subsequently received IFNα therapy, IFNAR2 expression at diagnosis was significantly higher in cytogenetic good responders than in poor responders. Down-regulation of IFNAR2 expression during IFNα therapy was observed only in good responders but not in poor responders. The encoded protein also functions as an antiviral factor. IFNAR2 may associate with IFNAR1 to form the type I interferon receptor. This protein serves as a receptor for interferons alpha and beta. IFNAR2 is also involved in IFN-mediated STAT1, STAT2, and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity. Following binding of IFNα2, IFNAR2 is internalized, but, instead of being routed towards degradation as it is when complexed to IFNβ, it recycles back to the cell surface. |
| Conjucates | PE |
| Others Formats | Unconjugated/APC/FITC |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Human IFNAR2 protein (TMPY-01642) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-IFNAR2 Antibody-PE (6Q627) | purchase Anti-IFNAR2 Antibody-PE (6Q627) | Anti-IFNAR2 Antibody-PE (6Q627) cost | order Anti-IFNAR2 Antibody-PE (6Q627)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.